Most of the US organ debate is about scarcity — too few organs, too many on the waitlist. The harder question is at the other end: the bedside of a dying patient, where recovery begins. When exactly does it begin, who decides, and who is watching for the patient rather than the organ? In 2025 the federal government answered part of that question in its own review, and the answer is unsettling. This is a sourced, deliberately de-identified account, built from the public record in OrganWatch. It documents the system; it names no patient and describes no individual case.
The rule that is supposed to hold the line
Transplant ethics rests on the dead-donor rule: a donor must be dead before vital organs are recovered, and the act of recovery must not be what causes death. Two paths to donation exist — after brain death, and after circulatory death (DCD), where the heart stops following withdrawal of life support. DCD is where the timing gets fraught, because it compresses determination of death, family grief, and a surgical clock into the same few minutes. A newer technique, normothermic regional perfusion (NRP), restarts circulation in the body after circulatory death is declared — which a number of physicians and ethicists argue is in direct tension with the basis on which death was just declared. The rule is clear; the practice at the edge is not.
What federal reviewers found
In 2025 HRSA reviewed 351 DCD cases in which donation was authorized but not completed. It found concerning features in 103 of them — roughly 29%: failure to recognize neurologic function inconsistent with proceeding, failure to recognize an improving patient condition, failure to work collaboratively with the patient's own medical team, failure to respect family wishes, and inadequate documentation. The agency concluded that a number of patients may not have been deceased when procurement steps were initiated. The review centered on a single OPO (formerly the Kentucky Organ Donor Affiliates). HRSA opened its investigation in March 2025, issued a corrective-action plan in May 2025, directed the OPTN to reopen a closed safety case, and Congress held oversight hearings. This is the de-identified, aggregate form of major reporting in which dozens of medical workers across many states described cases where recovery processes began on patients showing signs of life. It is a government finding with a case-count denominator — not an allegation.
Why the structure produces it
The pressure is built in. Hospitals are required to notify the local OPO of imminent deaths; the OPO — a regional monopoly now graded by CMS on how aggressively it recovers — sends its own staff to the bedside to pursue authorization and recovery. The entity measured on procurement is thus present at the moment a patient's prognosis is still being decided, alongside (and sometimes in tension with) the patient's own care team. Add a metric regime that rewards more recovery, and the conflict of interest is structural, not personal. CMS issued new donor-hospital responsibility guidance in 2026 stating the obvious — that patients must receive full medical care regardless of donation status — which is itself a tell that the line had blurred.
The system around it
The same reviews surfaced adjacent dysfunction: the GAO reported that about 19% of 2024 organ allocations were made out of sequence, bypassing the ranked match list, and HRSA directed that the practice be remediated. Large shares of recovered organs — especially kidneys — are never transplanted. A system that struggles to allocate and use the organs it already recovers is also the one applying pressure at the bedside to recover more. OrganWatch's bedside section collects these findings with their sources.
How this is documented — and how it isn't
Every claim here is a federal finding, professional-society position, or major published investigation, source-linked in OrganWatch. It is written at the aggregate and institutional level only — the 351-case denominator, the percentage, the named OPO and agency, the rule and the controversy. It carries no patient or family name, age, location, or case detail, by deliberate design: the people at this bedside are the most vulnerable in the entire system, and a record that exposed them would commit the very wrong it documents. The accountability is the system's, not theirs.
The data: OrganWatch — the source-linked map, including the bedside, consent-gap, and follow-the-money findings.
The series: the monopoly & decertification, unclaimed bodies & consent, and the money behind the system; plus the state-by-state consent map.